Keybanc analyst Scott Schoenhaus has reiterated an Overweight rating on Progyny (PGNY) and increased its price target from $30 to $35. This indicates a continued positive outlook from the analyst, suggesting potential upside for the stock based on their valuation models.
Keybanc analyst Scott Schoenhaus maintained an 'Overweight' rating on Progyny (PGNY) and raised the price target from $30 to $35. This action signals continued confidence in the company's prospects and suggests that the analyst believes the stock has further upside potential. This news is primarily positive for current and prospective PGNY shareholders, as it could lead to increased investor interest and potentially a short-term bump in the stock price. While not a fundamental change in the company's operations, analyst upgrades and price target increases can influence market sentiment and trading activity, offering a potential opportunity for traders looking for momentum plays.